[HTML] plos.org

[HTML][HTML] Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho, CY Lee… - PLoS …, 2014 - journals.plos.org
ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor,
crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the …
被引用次数：85 相关文章
[PDF] researchgate.net

[PDF][PDF] Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho, CY Lee… - 2014 - researchgate.net
ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor,
crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the …

[引用][C] Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho, CY Lee… - PLoS ONE, 2014 - cir.nii.ac.jp
Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and
Comparison with ALK Rearrangements | CiNii Research CiNii 国立情報学研究所 学術情報 …

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho… - PloS …, 2014 - yonsei.elsevierpure.com
ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor,
crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the …

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho, CY Lee… - PLoS ONE, 2014 - go.gale.com
ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor,
crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the …
[PDF] psu.edu

[PDF][PDF] Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho, CY Lee… - 2014 - Citeseer
ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor,
crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the …

Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements.

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho… - PLoS …, 2014 - search.ebscohost.com
Abstract< i> ROS1</i> rearrangement is a predictive biomarker for response to the tyrosine
kinase inhibitor, crizotinib. We investigated the usefulness of ROS1 immunohistochemistry …
[PDF] semanticscholar.org

[PDF][PDF] Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho, CY Lee… - 2014 - pdfs.semanticscholar.org
ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor,
crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the …

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho… - PloS …, 2014 - pubmed.ncbi.nlm.nih.gov
ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor,
crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the …

Screening of ROS1 rearrangements in lung adenocarcinoma by immunohistochemistry and comparison with ALK rearrangements.

YJ Cha, JS Lee, HR Kim, SM Lim, BC Cho, CY Lee… - Plos one, 2014 - europepmc.org
ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor,
crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the …